April 24, 2014 6:05 PM ET

Biotechnology

Company Overview of Predictive Biomarker Sciences, Inc.

Executive Profile

Andrew R. Allen M.D., Ph.D.

Co-Founder, Chief Medical Officer and Executive Vice President of Clinical & Pre-Clinical Development, Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
46$1,308,583
As of Fiscal Year 2012

Background

Dr. Andrew R. Allen, M.D., Ph.D. Co-Founded Clovis Oncology, Inc. on April 20, 2009 and has been its Chief Medical officer and Executive Vice President of Clinical & Pre-Clinical Development since April 20, 2009. Dr. Allen has been the Chief Medical Officer of Pharmion Corp., since May 18, 2006 and has been its Executive Vice President since August 2006. Dr. Allen served as a Vice President of BioPharma Development and Head of the Oncology Therapeutic Unit for Chiron. ...

Corporate Headquarters

2036 East Hackamore Street
Mesa, Arizona 85213

United States

Phone: 602-418-9300
Fax: 480-247-5493

Board Members Memberships

Director

Education

Master's Degree
The Royal College of Physicians
Unknown/Other Education
University of Oxford
PhD
Imperial College

Other Affiliations

Annual Compensation

Salary$384,583
Bonus$123,680
Total Annual Compensation$508,263

Stocks Options

All Other Compensation$15,885
Exercisable Options$30,172
Exercisable Options Value$383,788
Unexercisable Options$88,793
Unexercisable Options Value$493,447
Total Value of Options$877,234
Total Number of Options$118,965

Total Compensation

Total Annual Cash Compensation$524,148
Total Short Term Compensation$508,263
Other Long Term Compensation$15,885
Total Calculated Compensation$1,308,583
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Predictive Biomarker Sciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.